Relationship Between Coronary Angiography Findings and Fractional Flow Reserve After Balloon Angioplasty
PROBE-FFR
A PRospective Observational Study on the Relationship BEtween Coronary Angiography Findings and Fractional Flow Reserve After Balloon Angioplasty: PROBE-FFR
1 other identifier
observational
43
1 country
2
Brief Summary
The goal of this prospective observational study is to learn about in patients who need percutaneous coronary intervention for coronary artery disease. The main questions it aims to answer are:
- Fractional flow reserve according to coronary angiography findings after coronary artery balloon angioplasty
- Differences in fractional blood flow reserve before and after lesions between coronary balloon angioplasty using a scoring balloon and a regular balloon Participants will voluntarily consent to the study after being fully informed about the study and given ample opportunity to ask questions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2022
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 20, 2022
CompletedFirst Submitted
Initial submission to the registry
January 20, 2023
CompletedFirst Posted
Study publicly available on registry
February 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2026
CompletedFebruary 4, 2026
February 1, 2026
2.1 years
January 20, 2023
February 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Differences in fractional flow reserve (FFR) according to angiographic findings after coronary artery balloon angioplasty
Coronary angiographic findings and fractional flow within 15 minutes after coronary balloon angioplasty are collected and analyzed.
15 minutes
Secondary Outcomes (6)
Comparison of differences in fractional flow reserve (FFR) before and after lesions between coronary balloon angioplasty using a scoring balloon and a regular balloon
1 year
1-year outcome
1 year
Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific minimum lumen area
1 year
Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific plaque burden
1 year
Relationship between fractional blood flow reserve and intravascular ultrasound lesion-specific positive remodeling
1 year
- +1 more secondary outcomes
Eligibility Criteria
Patients who met the inclusion criteria and underwent interventions, as determined by clinical necessity, using fractional blood flow reserve (FFR) after percutaneous coronary angiography (PCA) will be included in the study.
You may qualify if:
- Patients with clinically stable coronary artery disease
- Patients undergoing balloon angioplasty as an interventional procedure (FFR-guided PCI) using coronary artery fractional blood flow reserve for de novo lesions with a standard vessel diameter of 2.25 mm or more under percutaneous coronary angiography (hereafter referred to as coronary angiography)
- (Note) If there are other lesions in the proximal area and the FFR of the distal lesion is collected, it is included in the selection target regardless of whether or not the proximal lesion was operated on.
You may not qualify if:
- Target lesion with stenosis of less than 50% or greater than 90% of the internal diameter
- Procedure for restenosis within the stent
- Pre-dilation performed on the target lesion before the coronary artery fractional blood flow reserve test
- Prior coronary artery bypass surgery
- Clinically unstable or ST-segment elevation myocardial infarction
- Myocardial infarction in the region supplied by the target vessel
- Target vessel is a blood vessel that supplies collateral circulation for occlusion of other blood vessels (not applicable when the need for collateral circulation has been resolved due to the opening of another vessel occlusion)
- Left ventricular ejection fraction (EF) less than 30%
- Most recently measured eGFR is less than 30 right before the procedure
- Accompanying primary valve disease requiring treatment
- Accompanying primary heart disease such as dilated cardiomyopathy, hypertrophic cardiomyopathy, or restrictive cardiomyopathy
- Congenital heart disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Ewha Womans University Mokdong Hospital
Seoul, South Korea
Seou National University Hospital
Seoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Bon-Kwon Koo, MD
Seoul National University Hospital
- STUDY DIRECTOR
Bon-Kwon Koo, MD
Seoul National University Hospital
- PRINCIPAL INVESTIGATOR
Bon-Kwon Koo, MD
Seoul National University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 20, 2023
First Posted
February 8, 2023
Study Start
December 20, 2022
Primary Completion
January 31, 2025
Study Completion
January 31, 2026
Last Updated
February 4, 2026
Record last verified: 2026-02